Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,135 | 1,670 | 1,034 | 500 | 83 |
| Receivables | 721 | 649 | 790 | 961 | 821 |
| Inventories | 937 | 869 | 864 | 881 | 896 |
| Other current assets | 159 | 163 | 56 | 69 | 100 |
| TOTAL | $2,952 | $3,350 | $2,745 | $2,411 | $1,900 |
| Non-Current Assets | |||||
| PPE Net | 776 | 641 | 673 | 713 | 748 |
| Intangibles | 11 | 14 | 18 | 22 | 27 |
| Other Non-Current Assets | 93 | 98 | 129 | 0 | 0 |
| TOTAL | $881 | $753 | $820 | $736 | $775 |
| Total Assets | $3,833 | $4,103 | $3,564 | $3,147 | $2,675 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 984 | 740 | 1,062 | 1,558 | 1,231 |
| Accrued Expenses | 126 | 230 | 302 | 232 | 229 |
| TOTAL | $1,170 | $970 | $2,566 | $2,590 | $1,460 |
| Non-Current Liabilities | |||||
| TOTAL | $109 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,279 | $970 | $2,566 | $2,590 | $1,460 |
| Shareholders' Equity | |||||
| Common Shares | 30,706 | 29,621 | 26,435 | 25,622 | 25,622 |
| Retained earnings | -37,851 | -36,363 | -35,238 | -34,494 | -33,771 |
| Other shareholders' equity | 3,654 | 3,848 | 3,813 | 3,507 | 3,507 |
| TOTAL | $2,554 | $3,133 | $999 | $557 | $1,215 |
| Total Liabilities And Equity | $3,833 | $4,103 | $3,564 | $3,147 | $2,675 |